NYVTX
Price
$25.53
Change
-$0.67 (-2.56%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

NYVTX vs VFINX

Header iconNYVTX vs VFINX Comparison
Open Charts NYVTX vs VFINXBanner chart's image
Davis NY Venture A
Price$25.53
Change-$0.67 (-2.56%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
NYVTX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NYVTX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYVTX is a Hold and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. NYVTX (6.53B). VFINX pays higher dividends than NYVTX: VFINX (1.24) vs NYVTX (0.74). NYVTX was incepted earlier than VFINX: NYVTX (56 years) vs VFINX (48 years). NYVTX is a more actively managed with annual turnover of: 7.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than NYVTX: VFINX (0) vs NYVTX (1000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. NYVTX (2.04). VFINX return over 5 years is better than : 88.65 vs. NYVTX (-6.72).
NYVTXVFINXNYVTX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence56 years48 years-
Gain YTD0.26827.2751%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.53B1.37T0%
Annual Yield % from dividends0.741.2459%
Returns for 1 year2.0427.637%
Returns for 3 years-4.3330.99-14%
Returns for 5 years-6.7288.65-8%
Returns for 10 years-23.82193.62-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc